Welcome to our dedicated page for Carecloud news (Ticker: CCLD), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
CareCloud, Inc. reports developments in AI-powered healthcare technology and revenue cycle management for medical practices and health systems. Company updates center on electronic health records, practice management, medical billing, patient experience management, business intelligence, digital health, and AI product portfolios including stratusAI, cirrusAI, and Marketware.
Recurring news themes include quarterly results, guidance, customer selections, product expansion into inpatient EHR, RCM, and analytics, and capital-structure actions involving credit facilities and preferred-stock matters. Updates also address cross-sell strategy, automation initiatives, conference presentations, and operational performance across its Healthcare IT and Medical Practice Management activities.
CareCloud (Nasdaq: CCLD) announced that CEO Hadi Chaudhry and President Stephen Snyder will discuss the use of generative AI in healthcare. The discussion will take place in a fireside chat on June 4, 2024, during a virtual conference hosted by Maxim Group. CareCloud serves 2,600 physician practices across the U.S., and the leadership will highlight how generative AI can enhance healthcare services and operational efficiencies. The event aims to explore AI's broader impact on the healthcare industry.
CareCloud has promoted Crystal Williams to Chief Operating Officer (COO), effective May 21, 2024. Williams brings over 20 years of experience in revenue cycle management (RCM) and was previously VP of Client Operations at CareCloud. She aims to streamline operations and enhance profitability. Williams' prior roles include leadership positions at GE Healthcare, where she led initiatives to improve efficiencies, margins, and client revenue. This strategic move is intended to leverage CareCloud's global operations for better client experiences and patient outcomes.
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) announced its Q1 2024 financial results, reporting $26 million in revenue, down from $30 million in Q1 2023.
Despite lower revenue, the company achieved a GAAP operating income of $129,000, compared to a $223,000 loss in the previous year.
Net loss improved to $241,000 or $0.02 per share, from $401,000 or $0.28 per share in Q1 2023. Adjusted EBITDA fell to $3.7 million from $4.2 million, but cash from operations surged to $4.1 million from $1.0 million, and free cash flow reached $2.2 million, a significant improvement from a negative $2.0 million in Q1 2023.
Operationally, CareCloud identified $22 million in annualized expense reductions, with $15 million expected this year, and repaid $2 million of its credit facility.
The company is also leveraging generative AI to enhance efficiencies. CEO A. Hadi Chaudhry expressed optimism about the financial direction, highlighting improvements in cash flow metrics and profitability.
CareCloud, Inc. received an unsolicited offer to acquire the company for $5.00 per share of common stock and $25 redemption price per share of its Series B Preferred Stock. The Board of Directors declined the offer after thorough evaluation and retained an investment bank to assess the terms of its Series A Preferred Stock.
CareCloud, Inc. has retained Citizens JMP as its exclusive capital structure advisor after receiving an unsolicited indication of interest to acquire the company. The Board of Directors declined the proposal and Citizens JMP will evaluate CareCloud's capital structure for potential modifications to its Series A Preferred Stock.
CareCloud, Inc. partners with NJ Comprehensive Healthcare to enhance operational efficiency and reduce costs. NJCH adopts CareCloud's talkUltimate suite for revenue cycle management, electronic health records, and practice management solutions, aiming to streamline processes and boost workflow efficiency.
CareCloud, Inc. will announce its first-quarter 2024 financial results on May 14, 2024. The company is a prominent provider of healthcare technology solutions in the medical industry. The results will be disclosed before the market opens, followed by an investor conference call at 8:30 a.m. Eastern Time. Interested parties can access the live webcast and presentation slides on the company's investor relations website. A replay will also be available shortly after the call.
Summary not available.
Summary not available.
Summary not available.